US2013059913A1PendingUtilityA1

Composition for amelioration of hypoalbuminemia

33
Assignee: DOI MASAKOPriority: Apr 7, 2010Filed: Mar 31, 2011Published: Mar 7, 2013
Est. expiryApr 7, 2030(~3.7 yrs left)· nominal 20-yr term from priority
Inventors:Masako DoiMasuhiro NishimuraNozomi Tamura
A61P 7/00A61P 43/00A61P 7/06A61K 31/198A23L 2/52A23V 2200/30A61P 3/00A23L 33/175A23V 2002/00
33
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to a composition for ameliorating hypoalbuminemia containing a branched-chain amino acid(s) as an active ingredient(s), wherein the composition contains leucine and/or isoleucine as the active ingredient(s) and does not contain valine. As the above branched-chain amino acid(s), leucine and isoleucine are preferably contained. The mass ratio of leucine to isoleucine described above is preferably from 0.1 to 10. As the above branched-chain amino acid(s), either leucine or isoleucine alone may be contained. The present invention is suitably used as an infusion formulation, an oral formulation or a food or drink.

Claims

exact text as granted — not AI-modified
1 . A composition for ameliorating hypoalbuminemia containing a branched-chain amino acid as an active ingredient, wherein the composition contains leucine and/or isoleucine and does not contain valine as an active ingredient. 
     
     
         2 . The composition for ameliorating hypoalbuminemia according to  claim 1 , wherein the composition contains leucine and isoleucine as the branched-chain amino acid. 
     
     
         3 . The composition for ameliorating hypoalbuminemia according to  claim 2 , wherein a mass ratio of the leucine to the isoleucine is from 0.1 to 10. 
     
     
         4 . The composition for ameliorating hypoalbuminemia according to  claim 1 , wherein the composition contains either leucine or isoleucine alone as the branched-chain amino acid. 
     
     
         5 . The composition for ameliorating hypoalbuminemia according to  claim 1 , in a form of infusion formulation. 
     
     
         6 . The composition for ameliorating hypoalbuminemia according to  claim 1 , in a form of oral formulation. 
     
     
         7 . The composition for ameliorating hypoalbuminemia according to  claim 1 , in a form of food or drink.

Join the waitlist — get patent alerts

Track US2013059913A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.